Noa Therapeutics
Annie Chevrier is an accomplished executive and legal professional with extensive experience in operations and paralegal roles. Currently serving as Executive Operations Lead and Executive Assistant at Noa Therapeutics since February 2025, Annie previously held the position of Executive Assistant to the President & CEO at Inversago Pharma, where responsibilities included managing complex schedules and facilitating communication with stakeholders in the biopharmaceutical sector. With a strong background in immigration law, Annie has worked as a Business Immigration Paralegal at BCF Avocats d'affaires and as an Immigration Paralegal at Silver Immigration. Past roles also include Paralegal and contract administrator at Metal Processing Group, Paralegal in the Administrative Services Department at ROBIC, and Corporate Paralegal at McCarthy Tétrault. Annie began a career in veterinary management as Practice Manager at The Animal Health Clinic. Annie holds a Certificat en droit social et du travail from UQAM and a Paralegal degree from College O'Sullivan.
This person is not in any teams
This person is not in any offices
Noa Therapeutics
Noa Therapeutics Inc. (Noa) is a preclinical Canadian biotech company aiming to defy the convention of traditional drug development to revolutionize treatment options for those living with complex inflammatory skin diseases. Leveraging intelligent design, Noa is pioneering the development of multimodal therapeutics; a singularly radical approach to address unmet needs and unlock opportunities within underserved and untapped markets. Targeting a first use case in atopic dermatitis, Noa’s non-steroidal small molecules aim to simultaneously addressing three constructive therapeutic targets. Through this multilateral approach, Noa strives to provide meaningful outcomes and establish a new, inclusive, standard for the first-line-treatment of inflammatory skin disease.